BARCELONA – The primary endpoint of the study was not met, thus differences between the long-acting insulins could not be confirmed.
Highest WATCH-DM scores linked to 5-year heart failure risk approaching 20%.
News from the FDA/CDC
It is the first glucagonlike peptide–1 receptor agonist treatment in pill form for this condition.
The designation is for reduction of cardiovascular death risk or disease progression in patients with reduced or preserved ejection fraction.
Metabolic surgery was associated with a significantly lower cumulative incidence of myocardial infarction, ischemic stroke, and mortality than...
Patients with prior PCI fared a bit better and may be a target population for long-term DAPT therapy.
From the Journals
The connection may be related to insulin resistance.